Fig. 2From: The importance of the lepidic component as a prognostic factor in stage I pulmonary adenocarcinomaThree-year recurrence-free survival among three groups of patients with stage I pulmonary adenocarcinoma and patients with stage IIA pulmonary adenocarcinoma. Group 1 = stage I disease with lepidic component ≤10 %; group 2 = stage I disease with lepidic component >10 % to 50 %; group 3 = stage I disease with lepidic component >50 %Back to article page